[Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib]. / Síndrome de lisis tumoral en un paciente con cáncer de riñón tratado con sunitinib.
Medicina (B Aires)
; 71(2): 158-60, 2011.
Article
em Es
| MEDLINE
| ID: mdl-21550933
The tumor lysis syndrome (TLS) is a metabolic disorder resulting from a massive tumor breakdown. It is characterized by hyperuricemia, hyperphosphatemia, hypocalcemia and hyperkalemia and predisposes to acute renal failure. TLS usually occurs after the initiation of cytotoxic therapy and is more frequent in the case of neoplasias with a high proliferative rate or that are highly chemo-sensitive. We report the case of a man with a recurrent kidney cancer who presented with a TLS and acute renal failure after initiation of sunitinib.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pirróis
/
Carcinoma de Células Renais
/
Síndrome de Lise Tumoral
/
Inibidores da Angiogênese
/
Indóis
/
Neoplasias Renais
Limite:
Humans
/
Male
/
Middle aged
Idioma:
Es
Revista:
Medicina (B Aires)
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
Argentina
País de publicação:
Argentina